Association of visceral adiposity index with new-onset type 2 diabetes and impaired fasting glucose in hypertensive Chinese adults
- PMID: 33844178
- DOI: 10.1007/s40519-021-01187-4
Association of visceral adiposity index with new-onset type 2 diabetes and impaired fasting glucose in hypertensive Chinese adults
Abstract
Purpose: Visceral adiposity index (VAI) is a reliable indicator for the distribution and function of adipose tissue in the body. The relation of VAI with new-onset type 2 diabetes and new-onset impaired fasting glucose (IFG) remains uncertain. We aimed to investigate the prospective relation of VAI with new-onset type 2 diabetes and new-onset IFG in Chinese hypertensive adults.
Methods: A total of 14,838 hypertensive adults free of type 2 diabetes at baseline were included from the China Stroke Primary Prevention Trial. The primary outcome was new-onset type 2 diabetes, defined as physician-diagnosed diabetes or use of glucose-lowering drugs during follow-up, or fasting glucose ≥ 7.0 mmol/L at the exit visit. The secondary outcome was new-onset IFG, defined as fasting glucose < 6.1 mmol/L at baseline, while fasting glucose ≥ 6.1 mmol/L and < 7.0 mmol/L at the exit visit.
Results: Over a median of 4.5 years' follow-up, 1612 (10.9%) participants developed type 2 diabetes. When VAI was categorized into quartiles, compared with participants in quartile 1-3 (< 2.80), significantly higher risk of new-onset type 2 diabetes (OR 1.30; 95% CI 1.08-1.56) and new-onset IFG (OR 1.28; 95% CI 1.08-1.52) was found in those in quartile 4 (≥ 2.80). Moreover, the positive associations were consistent in participants with or without single abnormal VAI components, including general obesity, abdominal obesity, elevated triglycerides and low high-density lipoprotein cholesterol (HDL-C) levels; or with different numbers of abnormal VAI components (all P interactions > 0.05).
Conclusion: Our study suggested a positive relation of VAI with the risk of new-onset type 2 diabetes and new-onset IFG in Chinese hypertensive patients, independent of its components.
Level of evidence: Level III, a well-designed cohort.
Keywords: Hypertension; New-onset impair fasting glucose; New-onset type 2 diabetes; Visceral adiposity index.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Triglycerides and waist to height ratio are more accurate than visceral adiposity and body adiposity index to predict impaired fasting glucose.Diabetes Res Clin Pract. 2019 Jul;153:49-54. doi: 10.1016/j.diabres.2019.05.019. Epub 2019 May 24. Diabetes Res Clin Pract. 2019. PMID: 31132383
-
Relationship of visceral adiposity index with new-onset proteinuria in hypertensive patients.Clin Nutr. 2021 Feb;40(2):438-444. doi: 10.1016/j.clnu.2020.05.031. Epub 2020 Jun 2. Clin Nutr. 2021. PMID: 32553428 Clinical Trial.
-
Associations between visceral adiposity index and incident nephropathy outcomes in diabetic patients: Insights from the ACCORD trial.Diabetes Metab Res Rev. 2023 Mar;39(3):e3602. doi: 10.1002/dmrr.3602. Epub 2022 Dec 30. Diabetes Metab Res Rev. 2023. PMID: 36546623
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Visceral adiposity index as a predictor for type 2 diabetes mellitus in Asian population: A systematic review.Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1231-1235. doi: 10.1016/j.dsx.2019.01.056. Epub 2019 Jan 30. Diabetes Metab Syndr. 2019. PMID: 31336469
Cited by
-
Severity of adipose tissue dysfunction is associated with progression of pre-diabetes to type 2 diabetes: the Tehran Lipid and Glucose Study.BMC Public Health. 2024 Jan 9;24(1):121. doi: 10.1186/s12889-023-17381-1. BMC Public Health. 2024. PMID: 38191327 Free PMC article.
-
Visceral Adiposity Index Plays an Important Role in Prognostic Prediction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.Front Cardiovasc Med. 2021 Nov 18;8:735637. doi: 10.3389/fcvm.2021.735637. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34869637 Free PMC article.
-
Association Between Visceral Obesity Index and Diabetes: A Systematic Review and Meta-analysis.J Clin Endocrinol Metab. 2024 Sep 16;109(10):2692-2707. doi: 10.1210/clinem/dgae303. J Clin Endocrinol Metab. 2024. PMID: 38709677 Free PMC article.
-
The cholesterol-HDL-glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy.J Diabetes Investig. 2025 Aug;16(8):1487-1494. doi: 10.1111/jdi.70086. Epub 2025 May 28. J Diabetes Investig. 2025. PMID: 40434226 Free PMC article.
-
Visceral adiposity index is positively associated with fasting plasma glucose: a cross-sectional study from National Health and Nutrition Examination Survey 2017-2020.BMC Public Health. 2023 Feb 11;23(1):313. doi: 10.1186/s12889-023-15231-8. BMC Public Health. 2023. PMID: 36774500 Free PMC article.
References
-
- Lin X, Xu Y, Xu J, Pan X, Song X, Shan L et al (2020) Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017. Endocrine 69(2):310–320 - PubMed
-
- Qin X, Zhang Y, Cai Y, He M, Sun L, Fu J et al (2013) Prevalence of obesity, abdominal obesity and associated factors in hypertensive adults aged 45–75 years. Clin Nutr 32(3):361–367 - PubMed
-
- Zhang X, Zhang M, Zhao Z, Huang Z, Deng Q, Li Y et al (2020) Geographic variation in prevalence of adult obesity in China: results from the 2013–2014 national chronic disease and risk factor surveillance. Ann Intern Med 172(4):291–293 - PubMed
-
- Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q et al (2017) Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 317(24):2515–2523 - PubMed
-
- Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R et al (2012) Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308(11):1150–1159 - PubMed
MeSH terms
Substances
Grants and funding
- 81973133/National Natural Science Foundation of China
- 81730019/National Natural Science Foundation of China
- 2016YFE0205400, 2018ZX09739010, 2018ZX09301034003/National Key Research and Development Program
- 201707020010/Science and Technology Planning Project of Guangzhou
- JSGG20170412155639040, GJHS20170314114526143, JSGG20180703155802047/Science, Technology and Innovation Committee of Shenzhen
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials